Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.83 USD | -2.62% | -5.85% | -14.06% |
Mar. 15 | Tranche Update on Champions Oncology, Inc.'s Equity Buyback Plan announced on April 5, 2023. | CI |
Mar. 13 | Craig-Hallum Downgrades Champions Oncology to Hold From Buy | MT |
Financials (USD)
Sales 2024 * | 48.84M | Sales 2025 * | 53.68M | Capitalization | 65.66M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 1.34 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.22 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 73.79% |
Latest transcript on Champions Oncology, Inc.
1 day | -2.62% | ||
1 week | -5.85% | ||
Current month | -0.41% | ||
1 month | -2.23% | ||
3 months | -20.82% | ||
6 months | -13.44% | ||
Current year | -14.06% |
Managers | Title | Age | Since |
---|---|---|---|
Ronnie Morris
CEO | Chief Executive Officer | 58 | 10-10-25 |
Brady Davis
PSD | President | - | 23-10-16 |
Joel Ackerman
CHM | Chairman | 59 | 10-10-25 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Sidransky
FOU | Founder | 64 | 07-12-31 |
Scott Tobin
BRD | Director/Board Member | 53 | 11-06-26 |
Joel Ackerman
CHM | Chairman | 59 | 10-10-25 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 4.83 | -2.62% | 483 |
24-05-09 | 4.96 | +2.06% | 545 |
24-05-08 | 4.86 | +2.53% | 2,555 |
24-05-07 | 4.74 | -3.27% | 3,906 |
24-05-06 | 4.9 | -4.48% | 12,834 |
Delayed Quote Nasdaq, May 10, 2024 at 04:30 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-14.06% | 65.66M | |
+17.96% | 44.96B | |
+48.77% | 41.85B | |
+1.17% | 42.65B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- CSBR Stock